EA200701756A1 - Соль производного пролина, её сольват и способ её получения - Google Patents

Соль производного пролина, её сольват и способ её получения

Info

Publication number
EA200701756A1
EA200701756A1 EA200701756A EA200701756A EA200701756A1 EA 200701756 A1 EA200701756 A1 EA 200701756A1 EA 200701756 A EA200701756 A EA 200701756A EA 200701756 A EA200701756 A EA 200701756A EA 200701756 A1 EA200701756 A1 EA 200701756A1
Authority
EA
Eurasian Patent Office
Prior art keywords
solvat
proline
derivative
salt
receiving
Prior art date
Application number
EA200701756A
Other languages
English (en)
Other versions
EA013119B1 (ru
Inventor
Томохиро Йосида
Хироси Сакасита
Наоко Уеда
Синдзи Кирихара
Сатору Уемори
Реико Цуцумиути
Фумихико Акахоси
Original Assignee
Мицубиси Фарма Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36916526&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200701756(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Мицубиси Фарма Корпорейшн filed Critical Мицубиси Фарма Корпорейшн
Publication of EA200701756A1 publication Critical patent/EA200701756A1/ru
Publication of EA013119B1 publication Critical patent/EA013119B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Настоящее изобретение относится к 3-{(2S,4S)-4-[4-(3-метил-1-фенил-1Н-пиразол-5-ил)пиперазин-1-ил]пирролидин-2-илкарбонил}тиазолидину (соединение I), который можно использовать как ингибитор дипептидилпептидазы-IV, имеет превосходные свойства стабильности и гигроскопичности, воспроизводимую структуру кристалла, и к способу его получения.
EA200701756A 2005-02-18 2006-02-17 Соль производного пролина, ее сольват и способ ее получения EA013119B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005041851 2005-02-18
PCT/JP2006/302827 WO2006088129A1 (ja) 2005-02-18 2006-02-17 プロリン誘導体の塩、またはその溶媒和物、及びその製造方法

Publications (2)

Publication Number Publication Date
EA200701756A1 true EA200701756A1 (ru) 2008-02-28
EA013119B1 EA013119B1 (ru) 2010-02-26

Family

ID=36916526

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200701756A EA013119B1 (ru) 2005-02-18 2006-02-17 Соль производного пролина, ее сольват и способ ее получения

Country Status (14)

Country Link
US (2) US8003790B2 (ru)
EP (2) EP2602259A3 (ru)
JP (3) JP4208938B2 (ru)
KR (2) KR20130076903A (ru)
CN (3) CN102372704B (ru)
AU (1) AU2006215041B2 (ru)
BR (1) BRPI0607863B8 (ru)
CA (1) CA2598301C (ru)
EA (1) EA013119B1 (ru)
ES (1) ES2588164T3 (ru)
MX (1) MX2007010054A (ru)
NZ (1) NZ561489A (ru)
TW (1) TWI403511B (ru)
WO (1) WO2006088129A1 (ru)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102372704B (zh) * 2005-02-18 2014-10-08 田边三菱制药株式会社 脯氨酸衍生物的盐，其溶剂合物，及其生产方法
ES2355156T3 (es) * 2005-04-26 2011-03-23 Mitsubishi Tanabe Pharma Corporation Agente profiláctico/terapéutico para las anomalías del metabolismo lipídico.
EP2143443B1 (en) 2007-04-03 2014-11-19 Mitsubishi Tanabe Pharma Corporation A combination of dipeptidyl peptidase iv inhibitor and sweetener for use in the treatment of obesity
CL2008003653A1 (es) 2008-01-17 2010-03-05 Mitsubishi Tanabe Pharma Corp Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
EA031225B1 (ru) 2008-08-15 2018-12-28 Бёрингер Ингельхайм Интернациональ Гмбх Ингибиторы дпп-4 для заживления ран
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
AR075204A1 (es) 2009-01-29 2011-03-16 Boehringer Ingelheim Int Inhibidores de dpp-4 y composiciones farmaceuticas que los comprenden, utiles para tratar enfermedades metabolicas en pacientes pediatricos, particularmente diabetes mellitus tipo 2
KR20160143897A (ko) 2009-02-13 2016-12-14 베링거 인겔하임 인터내셔날 게엠베하 Ｄｐｐ－４ 억제제(리나글립틴)을 임의로 다른 당뇨병 치료제와 병용하여 포함하는 당뇨병 치료 약제
AR077642A1 (es) 2009-07-09 2011-09-14 Arena Pharm Inc Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
MX364651B (es) 2009-11-27 2019-05-03 Boehringer Ingelheim Int Gmbh Star Inhibidores de dpp-iv, tales como la linagliptina, y composiciones farmacéuticas o combinaciones que comprenden los mismos, para usarse en el tratamiento de pacientes diabéticos tipificados genéticamente.
TWI418370B (zh) * 2009-12-18 2013-12-11 Mitsubishi Tanabe Pharma Corp 溶出安定性製劑
JP2013522279A (ja) 2010-03-18 2013-06-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糖尿病及び関連状態の治療で用いるｇｐｒ１１９作動薬とｄｄｐ−ｉｖ阻害薬リナグリプチンの組合せ
CA2795513A1 (en) 2010-04-06 2011-10-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
KR101927068B1 (ko) 2010-05-05 2018-12-10 베링거 인겔하임 인터내셔날 게엠베하 체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법
MX2012014247A (es) 2010-06-24 2013-01-18 Boehringer Ingelheim Int Terapia para la diabetes.
CA2812061A1 (en) 2010-09-22 2012-03-29 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012135570A1 (en) 2011-04-01 2012-10-04 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145361A1 (en) 2011-04-19 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145603A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140051714A1 (en) 2011-04-22 2014-02-20 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
JP5863789B2 (ja) * 2011-06-01 2016-02-17 田辺三菱製薬株式会社 ピラゾール誘導体の製造方法
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
AU2012299223A1 (en) 2011-08-19 2014-02-27 Merck Sharp & Dohme Corp. Process and intermediates for preparing macrolactams
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
US9518048B2 (en) 2012-08-31 2016-12-13 Glenmark Pharmaceuticals Limited Process for the preparation of teneligliptin
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
US11407721B2 (en) 2013-02-19 2022-08-09 Amgen Inc. CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
JOP20200296A1 (ar) 2013-06-10 2017-06-16 Amgen Inc عمليات صنع وأشكال بلورية من mdm2 مثبط
CN104230917B (zh) * 2013-06-24 2017-04-05 南京华威医药科技开发有限公司 一种脯氨酸衍生物盐的水合物及其生产方法
WO2015019239A1 (en) 2013-08-06 2015-02-12 Ranbaxy Laboratories Limited Process for the preparation of 1-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazine
WO2015019238A1 (en) 2013-08-06 2015-02-12 Ranbaxy Laboratories Limited Process for the preparation of n-protected (5s)-5-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidin-3-one
WO2015063709A1 (en) 2013-10-31 2015-05-07 Ranbaxy Laboratories Limited Process for the preparation of 1-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazine
CN104650065A (zh) * 2013-11-22 2015-05-27 天津市汉康医药生物技术有限公司 一种替格列汀化合物
WO2015173779A1 (en) 2014-05-16 2015-11-19 Micro Labs Limited Process for the preparation of teneligliptin and its novel intermediates
CN105294673B (zh) * 2014-06-18 2018-04-13 四川科伦药物研究院有限公司 一种氢溴酸替格列汀的合成方法
MX2018006006A (es) * 2017-02-03 2019-05-16 Glenmark Pharmaceuticals Ltd Sales de oxalato de teneligliptin y solvatos de este, intermediarios, proceso de preparacion y marcadores de estos.
CN108727364A (zh) * 2017-04-18 2018-11-02 乳源东阳光药业有限公司 一种氢溴酸替格列汀无定型及其制备方法
WO2019205021A1 (zh) * 2018-04-25 2019-10-31 乳源东阳光药业有限公司 一种氢溴酸替格列汀无定型及其制备方法
KR102494848B1 (ko) * 2018-10-10 2023-02-02 주식회사 파마코스텍 테네리글립틴 2토실산염 2수화물의 결정형 ⅰ형 및 그 제조방법
KR20200127480A (ko) 2019-05-02 2020-11-11 연성정밀화학(주) 테네리글립틴 에디실산염 결정형 및 이의 제조방법
KR20210121421A (ko) 2020-03-30 2021-10-08 코오롱생명과학 주식회사 테네리글리프틴 2.5브롬화수소산염 무정형의 제조방법
JP2022069426A (ja) * 2020-10-23 2022-05-11 マイラン ラボラトリーズ リミテッド テネリグリプチン２．５臭化水素酸塩のアモルファスを調製する方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1062357A (en) * 1965-03-23 1967-03-22 Pfizer & Co C Quinazolone derivatives
US4337341A (en) * 1976-11-02 1982-06-29 Eli Lilly And Company 4a-Aryl-octahydro-1H-2-pyrindines
IL111785A0 (en) 1993-12-03 1995-01-24 Ferring Bv Dp-iv inhibitors and pharmaceutical compositions containing them
US6090786A (en) * 1994-06-10 2000-07-18 Fondatech Benelux N.V. Serine proteases, their activity and their synthetic inhibitors
DE122010000020I1 (de) 1996-04-25 2010-07-08 Prosidion Ltd Verfahren zur Senkung des Blutglukosespiegels in Säugern
TW492957B (en) 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
DE19823831A1 (de) 1998-05-28 1999-12-02 Probiodrug Ges Fuer Arzneim Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
US20030176357A1 (en) * 1998-10-06 2003-09-18 Pospisilik Andrew J. Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
JP2003520849A (ja) 2000-01-24 2003-07-08 ノボ ノルディスク アクティーゼルスカブ 酵素ｄｐｐ−ｉｖの阻害剤であるｎ−置換２−シアノピロールおよび−ピロリン
EP1301187B1 (en) 2000-07-04 2005-07-06 Novo Nordisk A/S Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv)
NZ524618A (en) * 2000-08-10 2004-08-27 Mitsubishi Pharma Corp Proline derivatives and use thereof as drugs
DE60221098T2 (de) 2001-02-02 2008-01-24 Takeda Pharmaceutical Co. Ltd. Kondensierte heterocyclische derivate
GB0115517D0 (en) * 2001-06-25 2001-08-15 Ferring Bv Novel antidiabetic agents
US20040259883A1 (en) * 2001-09-14 2004-12-23 Hiroshi Sakashita Thiazolidine derivative and medicinal use thereof
WO2004099134A2 (en) * 2003-05-05 2004-11-18 Prosidion Ltd. Glutaminyl based dp iv-inhibitors
AU2003902946A0 (en) * 2003-06-12 2003-06-26 Fujisawa Pharmaceutical Co., Ltd. Dpp-iv inhibitor
JP4569802B2 (ja) 2003-07-23 2010-10-27 眞 八藤 ビタミンを主材とするイオン化ミネラル結合型サプリメントの製造方法
CN102372704B (zh) * 2005-02-18 2014-10-08 田边三菱制药株式会社 脯氨酸衍生物的盐，其溶剂合物，及其生产方法
ES2355156T3 (es) 2005-04-26 2011-03-23 Mitsubishi Tanabe Pharma Corporation Agente profiláctico/terapéutico para las anomalías del metabolismo lipídico.
PT1894567E (pt) 2005-06-03 2012-11-21 Mitsubishi Tanabe Pharma Corp Agentes farmacêuticos concomitantes e sua utilização

Also Published As

Publication number Publication date
BRPI0607863B1 (pt) 2020-10-20
KR20130076903A (ko) 2013-07-08
TWI403511B (zh) 2013-08-01
CN101119991A (zh) 2008-02-06
US20090216016A1 (en) 2009-08-27
US8604198B2 (en) 2013-12-10
JP2008214358A (ja) 2008-09-18
TW200640920A (en) 2006-12-01
KR20070108247A (ko) 2007-11-08
EP1854795A4 (en) 2009-03-25
EP1854795A1 (en) 2007-11-14
AU2006215041A1 (en) 2006-08-24
CA2598301C (en) 2013-05-28
KR101352650B1 (ko) 2014-01-16
EP2602259A3 (en) 2014-09-10
CA2598301A1 (en) 2006-08-24
EP2602259A2 (en) 2013-06-12
US8003790B2 (en) 2011-08-23
EA013119B1 (ru) 2010-02-26
JPWO2006088129A1 (ja) 2008-07-03
ES2588164T3 (es) 2016-10-31
BRPI0607863A2 (pt) 2010-06-22
CN102372704A (zh) 2012-03-14
WO2006088129A1 (ja) 2006-08-24
US20110282058A1 (en) 2011-11-17
JP2013032376A (ja) 2013-02-14
AU2006215041B2 (en) 2012-05-31
CN102372704B (zh) 2014-10-08
NZ561489A (en) 2010-10-29
CN101119991B (zh) 2012-01-25
CN102372705A (zh) 2012-03-14
BRPI0607863B8 (pt) 2021-05-25
MX2007010054A (es) 2007-09-21
EP1854795B1 (en) 2016-06-01
JP4208938B2 (ja) 2009-01-14

Similar Documents

Publication Publication Date Title
EA200701756A1 (ru) Соль производного пролина, её сольват и способ её получения
EA200700720A1 (ru) Новые ингибиторы дипептидилпептидазы iv, содержащие их фармацевтические композиции и процедура их приготовления
EA201000958A1 (ru) Пептидилнитрилы и их применение в качестве ингибиторов дипептидилпептидазы i
TW201129553A (en) Dipeptidyl peptidase inhibitors
EA200702208A1 (ru) Ингибиторы дипептидилпептидазы-iv
EA200970050A1 (ru) Ингибиторы пролилгидроксилаз
NO20073791L (no) Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer
RU2012103851A (ru) Би-арил-мета-пиримидиновые ингибиторы киназ
EA200600935A1 (ru) Гетероциклические соединения бороновой кислоты
EP1819674A4 (en) FUSIONED AMINOPIPERIDINES AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV FOR TREATING OR PREVENTING DIABETES
ATE554085T1 (de) Neue inhibitoren von glutaminylcyclase
RS51106B (sr) Derivati prolina i njihova upotreba kao inhibitora dipeptidil peptidaze iv
WO2007079199A3 (en) Substituted bis-amide metalloprotease inhibitors
NO20071242L (no) Triazolpyridinylsulfanylderivater som P38-MAP-kinaseinhibitorer
EA201001359A1 (ru) Гетероциклические соединения в качестве ингибиторов cxcr2
NO20075809L (no) DNA-PK inhibitorer
PE20130239A1 (es) Compuestos heteroaril-aril-ureas como inhibidores de la quinasa
ATE549926T1 (de) Kondensierte aminopiperidine als dipeptidylpeptidase-iv-inhibitoren zur behandlung oder prävention von diabetes
TW200714589A (en) Phenylacetamides suitable as protein kinase inhibitors
EA200970149A1 (ru) Производные n-(аминогетероарил)-1h-индол-2-карбоксамидов, их получение и их применение в терапии
EA201000566A1 (ru) Гетероциклические сетр ингибиторы
EP1794120A4 (en) peptidase
GEP20104941B (en) Pyrrolopyridine-based inhibitors of dipeptidyl peptidase iv and methods
EA200500312A1 (ru) Новые спироконденсированные хиназолиноны и их применение в качестве ингибиторов фосфодиэстераз
NO20063944L (no) Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM